Duke University Hospital is a 957-acute care bed academic tertiary care facility located in Durham, North Carolina.

There are 957 beds in Duke University Health System.

During the past decade, Duke University Health System conducted 250 clinical trials. In the 10-year time frame, 250 clinical trials started and 87 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 125 clinical trials started and 54 clinical trials were completed. i.e. 43.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duke University Health System" #1 sponsor was "Duke University" with 155 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 38 trials sponsored, "Pfizer" with 10 trials sponsored, "Novartis Pharmaceuticals" with 6 trials sponsored and "AIDS Clinical Trials Group" with 6 trials sponsored. Other sponsors include 190 different institutions and companies that sponsored additional 161 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke University Health System" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator, "National Institutes of Health (NIH)" with 14 trials as a collaborator, "Duke University" with 10 trials as a collaborator, "Genentech, Inc." with 8 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials as a collaborator. Other collaborators include 298 different institutions and companies that were collaborators in the rest 192 trials.

According to Clinical.Site data, the most researched conditions in "Duke University Health System" are "HIV Infections" (36 trials), "Glioblastoma" (18 trials), "Gliosarcoma" (16 trials), "Heart Failure" (11 trials) and "Covid19" (8 trials). Many other conditions were trialed in "Duke University Health System" in a lesser frequency.

Most popular intervention types in "Duke University Health System" are "Drug" (210 trials), "Other" (57 trials), "Device" (53 trials), "Biological" (36 trials) and "Behavioral" (32 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Saline" (8 trials), "Zidovudine" (7 trials), "Atazanavir" (4 trials) and "Efavirenz" (4 trials). Other intervention names were less common.

The vast majority of trials in "Duke University Health System" are 382 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 106 active trials in "Duke University Health System". 4 are not yet recruiting, 69 are recruiting, 29 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 244 completed trials in Duke University Health System, undefined suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Duke University Health System, 56 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 30 trials, and there were also 105 trials that are defined as “Not Applicable".

Duke University Health System has several departments that took part in Clinical trials: "Duke Children's Hospital" - 38 trials